Aggregate cash and cash equivalents and short-term investments were $297.9M and $412.3M at June 30, 2025 and December 31, 2024, respectively.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMMT:
- Summit Therapeutics Advances in Metastatic Colorectal Cancer Treatment with Phase II Trial
- 3 Stocks Flashing ‘Strong Buy’ Signals, According to Technical Analysis
- Summit Therapeutics Stock (SMMT) Jumps 8% on Talks of $15B Licensing Deal with AstraZeneca
- Biotech Alert: Searches spiking for these stocks today
- AstraZeneca discussing $15B partnership with Summit Therapeutics, Bloomberg says